AgeX Therapeutics, Inc. Common Stock (NY:AGE)

N/A UNCHANGED

Last Price Updated: 8:00 PM EDT, Mar 26, 2024 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Press Releases about AgeX Therapeutics, Inc. Common Stock

AGEX THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of AgeX Therapeutics, Inc. - AGE

February 27, 2024

From Kahn Swick & Foti, LLC

Via Business Wire

AgeX Therapeutics Reports Third Quarter 2023 Financial Results

November 14, 2023

From AgeX Therapeutics, Inc.

Via Business Wire

AGEX THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of AgeX Therapeutics, Inc. - AGE

September 05, 2023

From Kahn Swick & Foti, LLC

Via Business Wire

AGE Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of AgeX Therapeutics, Inc. Is Fair to Shareholders

August 30, 2023

From Halper Sadeh LLC

Via Business Wire

Serina Therapeutics and AgeX Therapeutics Enter into Merger Agreement

August 30, 2023

From AgeX Therapeutics, Inc.

Via Business Wire

AgeX Therapeutics Reports Second Quarter 2023 Financial Results

August 14, 2023

From AgeX Therapeutics, Inc.

Via Business Wire

AgeX Therapeutics Closes $36,000,000 Debt Exchange for Preferred Stock

July 24, 2023

From AgeX Therapeutics, Inc.

Via Business Wire

AgeX Therapeutics Announces $36,000,000 Debt Exchange for Preferred Stock

July 21, 2023

From AgeX Therapeutics, Inc.

Via Business Wire

AgeX Therapeutics Announces Appeal of NYSE American Determination

May 23, 2023

From AgeX Therapeutics, Inc.

Via Business Wire

AgeX Therapeutics Reports First Quarter 2023 Financial Results

May 12, 2023

From AgeX Therapeutics, Inc.

Via Business Wire

AgeX Therapeutics Receives Stock Exchange Deficiency Letter

April 26, 2023

From AgeX Therapeutics , Inc.

Via Business Wire

AgeX Therapeutics Reports Fourth Quarter and Annual 2022 Financial Results

March 31, 2023

From AgeX Therapeutics, Inc.

Via Business Wire

AgeX Therapeutics Receives Extension of Time to Attain Compliance With Stock Exchange Continued Listing Requirements

November 25, 2022

From AgeX Therapeutics, Inc.

Via Business Wire

AgeX Therapeutics Reports Third Quarter 2022 Financial Results

November 10, 2022

From AgeX Therapeutics, Inc.

Via Business Wire

AgeX Therapeutics Reports Second Quarter 2022 Financial Results

August 12, 2022

From AgeX Therapeutics, Inc.

Via Business Wire

Dr. Joanne Hackett Appointed Chairperson of AgeX Board of Directors

May 18, 2022

From AgeX Therapeutics, Inc.

Via Business Wire

AgeX Therapeutics Reports First Quarter 2022 Financial Results

May 13, 2022

From AgeX Therapeutics, Inc.

Via Business Wire

AgeX Therapeutics Reports Fourth Quarter and Annual 2021 Financial Results

March 29, 2022

From AgeX Therapeutics, Inc.

Via Business Wire

AgeX Therapeutics to Collaborate With University of California, Irvine, on Research Program for Exosome-Based Therapies for Certain Brain Disorders

December 14, 2021

From AgeX Therapeutics, Inc.

Via Business Wire

Braeden Lichti: The Business of Anti-Aging and Rejuvenation Biotechnology

December 31, 2021

VANCOUVER, British Columbia - Dec. 31, 2021 - PRLog -- 2020-07-30: Scientists now have a better understanding into the aging process, giving us a better explanation of the cellular changes that lead...

Via PRLog

Topics Artificial Intelligence Intellectual Property

AgeX Therapeutics’ Licensee ImStem Biotechnology Announces First U.S. Multiple Sclerosis Patient Dosed with IMS001

November 30, 2021

From AgeX Therapeutics, Inc.

Via Business Wire

AgeX Therapeutics Receives Stock Exchange Deficiency Letter

November 23, 2021

From AgeX Therapeutics , Inc.

Via Business Wire

AgeX Therapeutics Reports Third Quarter 2021 Financial Results

November 12, 2021

From AgeX Therapeutics, Inc.

Via Business Wire

AgeX Therapeutics Reports Second Quarter 2021 Financial Results

August 13, 2021

From AgeX Therapeutics, Inc.

Via Business Wire

AgeX Therapeutics and LyGenesis Terminate Merger Negotiations

July 23, 2021

From AgeX Therapeutics, Inc.

Via Business Wire

AgeX Therapeutics Reports First Quarter 2021 Financial Results and Provides Business Update

May 17, 2021

From AgeX Therapeutics

Via Business Wire

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.